University of Kentucky Markey Cancer Center | Strategic Alliance Partners

Latest from University of Kentucky Markey Cancer Center


Dr. D'Orazio on UV Signature Mutations in Melanoma

September 09, 2016

John A. D'Orazio, MD, PhD, associate professor, Department of Pediatrics, College of Medicine, University of Kentucky Markey Cancer Center, discusses ongoing research exploring ultraviolet radiation signature mutations in patients with melanoma.

Dr. O'Connor on Ongoing Breast Cancer Research

August 30, 2016

Kathleen L. O'Connor, MD, professor, associate director of Cancer Education, Department of Molecular and Cellular Biochemistry, University of Kentucky Markey Cancer Center, discusses the ongoing research in the field of breast cancer.

Zebrafish Are Making Waves as Cancer Models

June 30, 2016

The field of cancer biology is entering a postgenomic era in which most types of human cancer will have been extensively sequenced through efforts such as The Cancer Genome Atlas and the International Cancer Genome Consortium.

Trastuzumab-Associated Cardiac Events Reversible, Outweighed by Benefits

July 14, 2014

Cardiac events associated with trastuzumab are mostly reversible and outweighed by significant extensions in OS and PFS for patients with HER2-positive breast cancer, according to analyses from several clinical trials exploring the drug.